Inventor · disambiguated record
Melissa Rhodes
Also filed as: RHODES MELISSA · RHODES MELISSA C · RHODES MELISSA CLAIRE
4 granted patents·5 pending applications·7 citations·filing 2005–2023
67Inventor score
Files withALTAVANT SCIENCES GMBH4ERIMOS PHARMACEUTICALS LLC2AXOVANT SCIENCES LTD1FRAZER NEIL1KRIYA THERAPEUTICS INC1
Top patents by PatentIndex Score
9 records- 0187US11911382B2Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertensionALTAVANT SCIENCES GMBH·Filed 2022·Granted Feb 27, 2024·1 cites·8 claims
- 0285US11576915B2Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosingALTAVANT SCIENCES GMBH·Filed 2020·Granted Feb 14, 2023·2 cites·23 claims
- 0385US11413287B2Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertensionALTAVANT SCIENCES GMBH·Filed 2019·Granted Aug 16, 2022·3 cites·11 claims
- 0467US8440648B2Methods and compositions for treatment of intraepithelial neoplasiaFRAZER NEIL·Filed 2005·Granted May 14, 2013·1 cites·13 claims
- 0565US2024024316A1Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosingALTAVANT SCIENCES GMBH·Filed 2023·Application pending·0 cites
- 0657US2025288693A1Insulin and glucokinase gene therapy compositions and its use for treating diabetesKRIYA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0745US2009022803A1Oral Formulations For Delivery of Catecholic Butanes Including Ndga CompoundsERIMOS PHARMACEUTICALS LLC·Filed 2006·Application pending·0 cites
- 0845US2008096967A1Formulations for Injection of Catecholic Butanes, Including Ndga Compounds, Into AnimalsERIMOS PHARMACEUTICALS LLC·Filed 2006·Application pending·0 cites
- 0929US2016324852A1Compositions and methods of treating a neurodegenerative diseaseAXOVANT SCIENCES LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Melissa Rhodes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →